arrow_back Back Filing freshness 10-Q FY 2023 SEC EDGAR

VERDE BIO HOLDINGS, INC.

APHD
Price unavailable
Energy ·Crude Petroleum & Natural Gas ·USCrude Petroleum & Natural Gas
13 Visible periods
19 Metrics
Peer-ranked Benchmarks
Price Chart
28
Health
Poor
Bearish
auto_awesome

Analytical Summary

VERDE BIO HOLDINGS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth None
Op. Margin
ROIC -87.7%
FCF / Share
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close.

13-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
↓ -100.0%
Net Income Profit after all expenses
$-3.44M
↓ -3.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
9
Cash Quality
74

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 53 quarters